These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 1660811)

  • 41. Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes.
    Bachmann MF; Lutz MB; Layton GT; Harris SJ; Fehr T; Rescigno M; Ricciardi-Castagnoli P
    Eur J Immunol; 1996 Nov; 26(11):2595-600. PubMed ID: 8921944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition.
    Haurum JS; Tan L; Arsequell G; Frodsham P; Lellouch AC; Moss PA; Dwek RA; McMichael AJ; Elliott T
    Eur J Immunol; 1995 Dec; 25(12):3270-6. PubMed ID: 8566011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
    Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
    Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Competition inhibition of cytotoxic T-lymphocyte (CTL) lysis, a more sensitive method to identify candidate CTL epitopes than induction of antibody-detected MHC class I stabilization.
    Feltkamp MC; Vierboom MP; Toes RE; Ossendorp F; ter Schegget J; Melief CJ; Kast WM
    Immunol Lett; 1995; 47(1-2):1-8. PubMed ID: 8537084
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carrier-reactive hapten-specific cytotoxic T lymphocyte clones originate from a highly preselected T cell repertoire: implications for chemical-induced self-reactivity.
    Martin S; Ruh H; Hebbelmann S; Pflugfelder U; Rüde B; Weltzien HU
    Eur J Immunol; 1995 Oct; 25(10):2788-96. PubMed ID: 7589073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Major histocompatibility complex class I-binding peptides are recycled to the cell surface after internalization.
    Abdel Motal UM; Zhou X; Joki A; Siddiqi AR; Srinivasa BR; Stenvall K; Dahmén J; Jondal M
    Eur J Immunol; 1993 Dec; 23(12):3224-9. PubMed ID: 8258337
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Major histocompatibility complex regulation of T helper functions mapped to a peptide C terminus that controls ligand density.
    Murray JS; Ferrandis-Edwards D; Wolfe CJ; Schountz T
    Eur J Immunol; 1994 Oct; 24(10):2337-44. PubMed ID: 7925562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunization with glycosylated Kb-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells.
    Abdel-Motal UM; Berg L; Rosén A; Bengtsson M; Thorpe CJ; Kihlberg J; Dahmén J; Magnusson G; Karlsson KA; Jondal M
    Eur J Immunol; 1996 Mar; 26(3):544-51. PubMed ID: 8605919
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antigen processing mutant T2 cells present viral antigen restricted through H-2Kb.
    Zhou X; Glas R; Liu T; Ljunggren HG; Jondal M
    Eur J Immunol; 1993 Aug; 23(8):1802-8. PubMed ID: 8393799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides.
    Zhou X; Abdel Motal UM; Berg L; Jondal M
    Eur J Immunol; 1992 Dec; 22(12):3085-90. PubMed ID: 1446701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A defect in the presentation of intracellular viral antigens is restored by interferon-gamma in cell lines with impaired major histocompatibility complex class I assembly.
    Sibille C; Gould K; Hämmerling G; Townsend A
    Eur J Immunol; 1992 Feb; 22(2):433-40. PubMed ID: 1537379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recruitment of alloreactive cytotoxic T lymphocytes by an antigenic peptide.
    Staerz UD; Zepp F; Schmid R; Hill M; Rothbard J
    Eur J Immunol; 1989 Dec; 19(12):2191-6. PubMed ID: 2481586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Major histocompatibility complex (MHC) control of CD4 T cell subset activation. II. A single peptide induces either humoral or cell-mediated responses in mice of distinct MHC genotype.
    Murray JS; Pfeiffer C; Madri J; Bottomly K
    Eur J Immunol; 1992 Feb; 22(2):559-65. PubMed ID: 1347015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alloantigen-specific regulation of cytotoxic T cell responses is mediated through the induction of clonal anergy of CD8+ T cells.
    Schutze MP; Langlade-Demoyen P; Leclerc C
    Eur J Immunol; 1992 Feb; 22(2):387-92. PubMed ID: 1531638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Major histocompatibility complex class I-restricted presentation of influenza virus nucleoprotein peptide by B lymphoma cells harboring an antibody gene antigenized with the virus peptide.
    Billetta R; Filaci G; Zanetti M
    Eur J Immunol; 1995 Mar; 25(3):776-83. PubMed ID: 7705408
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of anchor residue modifications on the stability of major histocompatibility complex class I-peptide interactions.
    Neefjes JJ; Dierx J; Ploegh HL
    Eur J Immunol; 1993 Apr; 23(4):840-5. PubMed ID: 8384560
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The fate of the three subunits of major histocompatibility complex class I molecules.
    Neefjes JJ; Smit L; Gehrmann M; Ploegh HL
    Eur J Immunol; 1992 Jun; 22(6):1609-14. PubMed ID: 1318200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo CTL immunity can be elicited by in vitro reconstituted MHC/peptide complex.
    Sakita I; Hörig H; Sun R; Wang F; Nathenson SG
    J Immunol Methods; 1996 Jun; 192(1-2):105-15. PubMed ID: 8699005
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A quantitative assay to measure the interaction between immunogenic peptides and purified class I major histocompatibility complex molecules.
    Olsen AC; Pedersen LO; Hansen AS; Nissen MH; Olsen M; Hansen PR; Holm A; Buus S
    Eur J Immunol; 1994 Feb; 24(2):385-92. PubMed ID: 8299688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of major histocompatibility complex class I interaction with Epstein-Barr virus and human immunodeficiency virus peptides by elevation of membrane H-2 and HLA in peptide loading-deficient cells.
    Stuber G; Modrow S; Höglund P; Franksson L; Elvin J; Wolf H; Kärre K; Klein G
    Eur J Immunol; 1992 Oct; 22(10):2697-703. PubMed ID: 1327802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.